CAMBRIDGE, Mass.--(BUSINESS WIRE)--
InVivo Therapeutics Holdings Corp. (NVIV) announced today that
Tom Ulich, MD, InVivo’s Chief Scientific Officer, will present at the
4th Annual Partnering Forum, part of the Stem Cell Meeting on the Mesa
to be held October 7-9 in La Jolla, CA.
Dr. Ulich's presentation will take place at 3:00PM PDT on Tuesday,
October 7th at the Estancia La Jolla Hotel. A live video webcast of all
company presentations will be available at: http://stemcellmeetingonthemesa.com/webcast/
and will also be published on the Alliance for Regerative Medicine’s
website shortly after the event.
Organized by the Alliance for Regenerative Medicine (ARM), the
California Institute for Regenerative Medicine (CIRM) and the Sanford
Consortium for Regenerative Medicine, the 2014 Stem Cell Meeting on the
Mesa is a three-day conference aimed at bringing together senior
executives and top decision makers in the regenerative medicine industry
with the scientific community to advance cutting-edge research into
cures. The Partnering Forum is the first and only partnering meeting of
its kind dedicated solely to facilitating connections for the
regenerative medicine and advanced therapies industry.
The meeting also features a nationally recognized Scientific Symposium,
showcasing leading academic research in the field of regenerative
medicine. Combined, these meetings attract nearly 800 attendees from
around the globe, fostering key partnerships through one-on-one meetings
while also highlighting clinical and commercial progress in the field.
For more information, please visit: http://stemcellmeetingonthemesa.com/
Dr. Ulich said, “As we advance towards the clinic with our human neural
stem cell-coated Neural Spinal Scaffold, we look forward to illustrating
the benefits of our approach to the reconstitution of neural
connectivity in the spinal cord of patients with chronic motor and
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a pioneering biomaterials and
biotechnology company with a focus on treatment of spinal cord injuries.
The company was founded in 2005 with proprietary technology co-invented
by Robert Langer, ScD., Professor at Massachusetts Institute of
Technology, and Joseph P. Vacanti, MD, who is affiliated with
Massachusetts General Hospital. In 2011 the company earned the David S.
Apple Award from the American Spinal Injury Association for its
outstanding contribution to spinal cord injury medicine. The
publicly-traded company is headquartered in Cambridge, MA. For more
details, visit, www.invivotherapeutics.com.
InVivo Therapeutics Holdings Corp.
Brian Luque, 617-863-5535
Source: InVivo Therapeutics